National Taiwan University Hospital

Taipei, R.o.c 100

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, HER2 Positive Breast Cancer

Studies at this site

• Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL — Running, not enrolling
• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling